Calliditas Therapeutics’ Acquisition of Controlling Interest in Genkyotex SA

Paolo Bossi

Vinge KB advised Calliditas Therapeutics. Geneva-based Genkyotex, listed on the Euronext Paris and Euronext Brussels markets, announced an agreement for Calliditas Therapeutics AB to acquire a…

This content is for Standard 1 Year members only.
Login Join Now
Avatar

Author: Paolo Bossi

…

This content is for Standard 1 Year members only.
Login Join Now